Delivery Order SPE2DB20D1100-SPE2DB25FB1S1

Award Date 3/17/25
Potential Completion Date 3/18/25
Potential Value $3.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,156.16 firm-fixed-price delivery order is for the supply of 4567603444 DEXMETHYLPHENIDATE ER 10 MG CP 100S, a generic pharmaceutical product. The contract has an ultimate completion date of March 18, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $5,364.69, is for the delivery of DEXMETHYLPHENIDATE ER 20 MG CP 100S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,189.17 firm fixed-price delivery order is for the supply of 4568243958 - DEXMETHYLPHENIDATE ER CAPS 25MG, with a period of performance through May 15, 2025. The contract is not set aside and was awarded under Amerisourcebergen's existing $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,937.87, is a Delivery Order for 4563080930 DEXMETHYLPHENIDATE ER 20 MG CP 100S, a pharmaceutical product. The contract has an ultimate completion date of December 13, 2023, and is a Firm Fixed Price contract. This award is associated with a larger Indefinite Delivery Contract (IDC) between...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,535.48, is a delivery order for the supply of 4567887706 DEXMETHYLPHENIDATE ER 10 MG CP 100S. The contract has an ultimate completion date of April 14, 2025 and was awarded on April 11, 2025. The contract is a Firm Fixed Price agreement, with no set-aside designation. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,353.29, is for the delivery of DEXMETHYLPHENIDATE ER 25 MG CP 100S, a pharmaceutical product. The contract has a completion date of March 26, 2025 and is a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,037.21 firm fixed-price delivery order is for the provision of 4564894605 - DEXMETHYLPHENIDATE ER 20 MG CP 100S, with a period of performance through June 14, 2024. This contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of DEXMETHYLPHENIDATE ER 10 MG CP 100S. The fixed-price delivery order, valued at $1,063.28, has a period of performance through February 13, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,502.12, is a Delivery Order contract for the supply of DEXMETHYLPHENIDATE ER 30 MG CP 100S, a prescription medication. The contract has a ceiling value of $1,502.12 and an ultimate completion date of March 31, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,016.10 and is a delivery order contract with a firm fixed price pricing type. The contract is to provide DEXMETHYLPHENIDATE ER 15 MG CP 100S, a prescription medication, to support military healthcare programs. The contract has an ultimate completion date of February 13, 2025. This award...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FB1S1
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,827.24 Firm Fixed Price Delivery Order covers the supply of 4567612809 - DEXMETHYLPHENIDATE ER 10 MG CP 100S, with a completion date of March 18, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific award was not designated with a set-aside requirement, indicating open competition.

Generated 6/16/25, 10:42 AM